Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011, Limassol, Cyprus
Glibesyn 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. The product is a white, round, flat scored tablet, with 7.0mm diameter. The tablet can be divided into equal halves. |
Each Glibesyn tablet contains 5mg of glibenclamide.
Excipient with known effect: lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Glibenclamide |
Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Packs of 40, 100, 500 and 1000 tablets are available.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011, Limassol, Cyprus
19926
Date of first authorisation: 20.12.2005
Date of latest renewal:31.08.2012
| Drug | Countries | |
|---|---|---|
| GLIBESYN | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
